Percutaneous Left Atrial Appendage Occlusion-Current Evidence and Future Directions

Over the past two decades, percutaneous left atrial appendage occlusion (LAAO) has proven to be a viable alternative to oral anticoagulation (OAC) for stroke prevention in patients with atrial fibrillation (AF), in particular in those patients who are at increased risk for stroke and bleeding compli...

Full description

Saved in:
Bibliographic Details
Published in:Journal of clinical medicine 2023-11, Vol.12 (23), p.7292
Main Authors: Rotta Detto Loria, Johannes, Desch, Steffen, Pöss, Janine, Kirsch, Katharina, Thiele, Holger, Sandri, Marcus
Format: Article
Language:English
Subjects:
Anticoagulants
Atrial fibrillation
Blood clot
Blood clots
Catheterization
Catheters
Complications and side effects
Contraindications
Cost analysis
FDA approval
Health aspects
Heart atrium
Ischemia
Methods
Mortality
Older people
Patients
Physiological aspects
Prevention
Risk factors
Stroke
Stroke (Disease)
Systematic review
Thrombosis
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Over the past two decades, percutaneous left atrial appendage occlusion (LAAO) has proven to be a viable alternative to oral anticoagulation (OAC) for stroke prevention in patients with atrial fibrillation (AF), in particular in those patients who are at increased risk for stroke and bleeding complications. This systematic review provides a comprehensive evaluation of anatomical features, patient selection, procedural planning and execution, complications, medical treatment following the procedure, and contemporary outcome data.
ISSN:2077-0383
2077-0383
DOI:10.3390/jcm12237292